Literature DB >> 14450876

The genetic basis for the graft-against-host reaction between inbred lines of fowls. Differences between the Reaseheath C and I inbred lines.

W P JAFFE, L N PAYNE.   

Abstract

Keywords:  ANTIGEN-ANTIBODY REACTIONS; BLOOD TRANSFUSION; SPLENOMEGALY/experimental

Mesh:

Year:  1962        PMID: 14450876      PMCID: PMC1424100     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  6 in total

1.  Tolerance of skin grafts produced by various adutl cells, soluble extracts, and embryonic cells.

Authors:  P I TERASAKI
Journal:  J Embryol Exp Morphol       Date:  1959-09

2.  Identification of the type of blood-cell responsible for the graft-versus-host reaction in chicks.

Authors:  P I TERASAKI
Journal:  J Embryol Exp Morphol       Date:  1959-09

3.  The estimation of the number of histocompatibility genes controlling the successful transplantation of normal skin in mice.

Authors:  A D BARNES; P L KROHN
Journal:  Proc R Soc Lond B Biol Sci       Date:  1957-06-25

4.  The impact on the developing embryo and newborn animal of adult homologous cells.

Authors:  M SIMONSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1957

5.  Immunological attack on newborn chickens by injected adult cells.

Authors:  A G COCK; M SIMONSEN
Journal:  Immunology       Date:  1958-04       Impact factor: 7.397

6.  Successful skin homografts in inbred chickens.

Authors:  A G COCK; M CLOUGH
Journal:  Nature       Date:  1956-07-21       Impact factor: 49.962

  6 in total
  2 in total

1.  Alternatives to donor matching for control of graft-versus-host disease.

Authors:  H M Vriesendorp; W M Klapwijk; T P Visser; C Zurcher; D W van Bekkum
Journal:  Immunogenetics       Date:  1982-01       Impact factor: 2.846

2.  Primary immune response in grafted cells. Dissociation between the proliferation of activity and the proliferation of cells.

Authors:  N W Nisbet; M Simonsen
Journal:  J Exp Med       Date:  1967-06-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.